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Purpose—The aim of this study is to assess mental health services utilization and expenditures 
associated with cancer history using a nationally representative sample in the US.
Methods—We used data from the 2008–2011 Medical Expenditure Panel Survey and 
multivariate regression models to assess mental health services use and expenditures among 
cancer survivors compared to individuals without a cancer history, stratified by age (18–64 and 
≥65 years) and time since diagnosis (≤1 vs. >1 year).
Results—Among adults aged 18–64, compared with individuals without a cancer history, cancer 
survivors were more likely to screen positive for current psychological distress and depression 
regardless of time since diagnosis; survivors diagnosed >1 year ago were more likely to use 
mental health prescription drugs; those diagnosed within 1 year reported significantly lower 
annual per capita mental health drug expenditure and out-of-pocket mental health expenditure, 
while those diagnosed >1 year presented significantly higher annual per capita mental health 
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expenditure. No significant differences in mental health expenditures were found among adults 
aged 65 or older.
Conclusions—Mental health problems presented higher health and economic burden among 
younger and longer-term survivors than individuals without a cancer history. This study provides 
data for monitoring the impact of initiatives to enhance coverage and access for mental health 
services at the national level.
Implications for cancer survivors—Early detection and appropriate treatment of mental 
health problems may help improve quality of cancer survivorship.
Keywords
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Introduction
Addressing mental health needs of cancer survivors is important for optimizing quality of 
life and adaptation after cancer [1]. Psychological distress and depressive symptoms in 
cancer survivors are adversely associated with quality of life [2, 3], health behaviors [4], 
adherence to medical treatments [1], healthcare costs [5], and cancer progression and 
survival [6–8]. Although prevalence estimates vary by cancer site, time since diagnosis [9], 
and the way that mental health conditions are defined, approximately one third of cancer 
survivors have a mental health diagnosis [10–12].
The number of cancer survivors in the United States has grown to 13.7 million according to 
2013 estimates, with approximately 64 % diagnosed ≥5 years ago [13]. This population will 
continue to grow as the population ages and with improvements in cancer screening, early 
detection, and treatment [14]. Thus, the demand for mental health services among cancer 
survivors is expected to increase given both the growing number of survivors and the 
increased demand for mental health services observed in the general population over the past 
25 years [15, 16]. Efficacious and cost-effective treatments for psychological comorbidities 
in cancer survivors have been developed [17–19]. Several studies have found that cancer 
survivors are more likely to use mental health services than persons without a cancer history 
[11, 20, 21]. However, very limited research examined the utilization and expenditure 
among cancer survivors compared to those without a cancer history stratified by age and 
time since diagnosis. In addition, mental health services expenditure among cancer survivors 
have not been assessed at the national level nor have previous studies simultaneously 
considered mental health visits use and prescription drugs use, the latter of which accounts 
for a substantial and growing proportion of mental health services [22].
Given the projected shortage of the specialized medical workforce available to treat cancer 
survivors [23] and concerns about rising healthcare costs [24], it is important to quantify 
mental health services use and expenditures among cancer survivors, as well as survivors’ 
direct economic burden (out-of-pocket expenditures). In this study, we estimated (1) mental 
health needs and services use, including mental health-related prescriptions, among adult 
cancer survivors and individuals without a cancer history using a nationally representative 
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sample and (2) excess annual per capita and out-of-pocket mental health services 
expenditures among cancer survivors. This study provides data for understanding cancer 
survivors’ needs and use patterns of mental health services by age and time since diagnosis. 
These data are essential for monitoring the impact of initiatives to enhance coverage and 
access for mental health services at the national level.
Methods
Data source and study sample
This study included individuals who were 18 years or older and participated in the Medical 
Expenditure Panel Survey (MEPS) for 2008–2011 (http://meps.ahrq.gov/mepsweb/
survey_comp/household.jsp). The MEPS is an ongoing household survey developed to 
collect information on healthcare use and expenditures through in-person interviews using 
computer-assisted personal interview (CAPI). Data collection is initiated with a new sample 
(i.e., “panel”) each year that participates in MEPS for 2 years. MEPS data have been widely 
used to generate nationally representative estimates of healthcare use and expenditures for 
the civilian noninstitution-alized population in the US [16, 22, 25].
Cancer survivors were identified from a survey question which asked if a participant has 
ever been told by a doctor or other health professional that he/she had cancer or any other 
malignancy. Individuals who reported only nonmelanoma skin cancers were excluded from 
the study sample because the diagnosis and treatment of these malignancies are generally 
considered to be minor [26] and they are routinely excluded from other studies of cancer 
survivors [27–29]. Those with missing time since diagnosis were also excluded from this 
study (n=262) including those who reported age at diagnosis beyond the usual age range for 
diagnosis of each cancer [27]. In addition, we restricted the sample to those who were in the 
scope for the whole year to capture full-year utilization and expenditure. The current 
analytic sample consisted of 5,944 adult cancer survivors and 76,877 adults without a cancer 
history at the time of survey, representing 19.2 and 197.3 million people annually and 
nationally, respectively.
Measures
Sociodemographics, comorbidities, and time since cancer diagnosis—
Sociodemographic characteristics included age by the end of survey year, sex, race/
ethnicity, education, marital status, annual household income as a percentage of the federal 
poverty level (% FPL), health insurance coverage, having a usual source of care, smoking 
status (current smoker vs. nonsmoker), and body mass index (BMI; kg/m2).
Comorbidities were measured using the number of known MEPS priority conditions other 
than cancer (categorized as 0, 1, 2, 3, or 4+ priority conditions), which include high blood 
pressure, heart disease, stroke, emphysema, chronic bronchitis, high cholesterol, diabetes, 
joint pain, arthritis, and asthma.
Years since cancer diagnosis were calculated by subtracting survivors’ age at most recent 
cancer diagnosis from their current age. Time since diagnosis was categorized into ≤1 year 
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and >1 year, given that most expenditure for cancer treatment and psychosocial impact of 
cancer diagnosis occurred within the first year after diagnosis [25, 30, 31].
Current mental health needs
Screeners for psychological distress or depression included the Patient Health 
Questionnaire-2 (PHQ-2) and the Kessler 6. A positive screener for the PHQ-2 is a score of 
>2 [32], and a score of >12 for the Kessler 6 [33].
Mental health services use
Similar to previous publications which defined mental health conditions using the MEPS 
data [22], we defined mental health conditions by Clinical Classification Codes (CCC) 
650-1, 656-62, and 670, which include mood disorders, anxiety disorders, psychotic 
disorders, substance use disorders, and sleep disorders. Attention-deficit disorder, 
developmental disorders, other disorders diagnosed in infancy, childhood, or adolescence, as 
well as delirium, dementia, and other cognitive disorders were not included as mental health 
conditions.
Mental health services use was defined (yes/no) by whether an individual reported any 
mental health visits (office-based, out-patient, emergency room, or hospitalization visit) or 
prescription drugs use [22]. Mental health visits were abstracted from the inpatient, 
outpatient, office-based provider, or emergency room event files. A visit was considered to 
be related to mental health if any of the following were true: (1) reported as related to a 
mental health condition(s); (2) a psychiatrist, psychologist, or social worker was seen; (3) 
drug or alcohol treatment was received; or (4) psychotherapy or counseling was provided 
during the visit [ICD 9 procedure code 94]. The annual total number of mental health visits 
was summed for each participant.
Prescriptions were defined as for mental health if two criteria were met: (1) reported to be 
associated with a mental health condition (designated using CCCs) and (2) fell into one of 
several designated therapeutic classes, including antidepressants, antianxiety drugs 
(including beta blockers), antimanics/anticonvulsants, antipsychotics, sedatives/hypnotics, 
and drugs used for substance abuse [22]. Information on over-the-counter drugs is not 
available in MEPS and was not included in the estimates.
Mental health expenditures
Expenditures for mental health visits, mental health prescription drugs use, and total mental 
health expenditure (visits and prescriptions) were calculated by summing the out-of-pocket 
expenditure and third-party payments for inpatient, outpatient, office-based provider and 
emergency room visits, and prescription drugs.
Statistical analysis
First, sociodemographics and comorbidities among cancer survivors and individuals without 
a cancer history were compared using adjusted Wald tests for continuous variables and Rao-
Scott chi-square tests for categorical variables. Second, current mental health needs and 
mental health services use by cancer history were assessed using multivariate logistic 
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regression models. Third, per capita annual and out-of-pocket mental health expenditures 
associated with cancer history were analyzed by comparing expenditures among cancer 
survivors with individuals without a cancer history using a weighted two-part model to 
account for the significant number of nonusers of mental health services. The first part of the 
model estimates a logistic regression to predict any mental health services use. Generalized 
linear models with a gamma distribution and a log link function were used in the second part 
among users of mental health services to account for the highly skewed nature of medical 
spending [34, 35]. The predicted margin of per capita mental health expenditures and its 95 
% confidence interval by cancer history were estimated. Cancer survivors were further 
stratified by time since diagnosis (≤1 vs. >1 year). The method of predicted margins directly 
standardizes the outcome of each group to the covariate distribution of the population [36]. 
All expenditures were inflated to 2011 dollars using Personal Health Care Expenditure 
(PHCE) component of the National Health Expenditure Accounts (http://meps.ahrq.gov/
about_meps/Price_Index.shtml). Separate analyses were conducted by age group (18–64 and 
>65 years) to account for differences in insurance coverage, comorbidities, and psychosocial 




In both age strata (18–64 and ≥65 years), cancer survivors were more likely to be older, non-
Hispanic white, and to report some college or more education, a usual source of care, and 
more comorbidities than individuals without a cancer history (all p<0.01; Table 1). Among 
adults aged 18–64 years, cancer survivors were more likely to have public insurance only 
and less likely to be low-income or uninsured than individuals without a cancer history (all 
p<0.0l). Among adults aged 65 or older, cancer survivors were more likely to have any 
private insurance than individuals without a cancer history (p<0.00l). Among cancer 
survivors in this study sample, 86.3 % had been diagnosed >1 year ago. The top three most 
common cancer sites reported were breast (18.0 %), prostate (13.8 %), and melanoma (9.0 
%) (data not shown).
Mental health needs and use
Among adults aged 18–64, cancer survivors were more likely to screen positive for current 
psychological distress and depression than individuals without a cancer history regardless of 
time since diagnosis (p<0.05), in adjusted analysis (Table 2). Among adults aged 65 or 
older, cancer survivors diagnosed >1 year ago were more likely to screen positive for 
depression (p<0.0l) than individuals without a cancer history.
Among adults aged 18–64, cancer survivors diagnosed >1 year ago were more likely to use 
mental health prescription drugs (14.6 vs. 11.5 %, p<0.0l), while those diagnosed ≤1 year 
were less likely to use mental health prescription drugs (8.7 vs. 11.5 %, p<0.05) than 
individuals without a cancer history. Among those aged 65 or older, cancer survivors 
diagnosed >1 year ago were more likely to use mental health prescription drugs than 
individuals without a cancer history (16.4 vs. 13.6 %,p<0.05), while no significant 
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differences were found in newly diagnosed older adults. No significant differences in mental 
health visits use was found in either age strata.
Mental health expenditures
Among adults aged 18–64, cancer survivors diagnosed ≤1 year reported significantly lower 
out-of-pocket mental health expenditure ($18 vs. $41,p<0.01) and per capita annual mental 
health drug expenditure ($51 vs. $103, p<0.01) than individuals without a cancer history, in 
adjusted analysis (Table 3). Among survivors aged 18–64 and diagnosed >1 year ago, 
annual per capita mental health expenditure were about 45 % higher than individuals 
without a cancer history ($304 vs. $210, p<0.05) with no significant differences in the other 
three types of expenditure, in adjusted analysis.
Among those aged 65 or older, no significant difference in mental health expenditures was 
found between cancer survivors and individuals without a cancer history.
Discussion
Using a nationally representative sample from the 2008–2011 MEPS, we evaluated mental 
health services use and expenditures associated with cancer history in the USA. Mental 
health problems presented a significant health and economic burden among cancer survivors 
compared to individuals without a cancer history, especially among those aged 18–64 years 
and diagnosed more than 1 year ago. To the authors’ best knowledge, this is the first study to 
quantify the use and expenditures of both mental health visits and prescription drugs 
associated with cancer history at the national level, stratified by age and time since 
diagnosis. Given the substantial prevalence and impact of mental health problems among a 
growing population of cancer survivors, this study provides important information for 
comprehensive estimation of psychosocial burden associated with cancer history.
Our results emphasized the importance of stratification by age and time since diagnosis in 
assessing mental health needs and services use among cancer survivors, which has been 
overlooked in most previous studies [11, 20]. Younger adult survivors may experience more 
psychosocial events due to cancer diagnosis (such as change in employment status) [28, 31]. 
Elderly cancer survivors may underreport mental health problems associated with cancer 
diagnosis by taking those symptoms as part of normal aging process. Most cancer patients 
received intensive treatment for cancer and experienced psychosocial events related to 
cancer (e.g., early retirement or job loss) within the first year after their diagnosis [28, 30], 
treatment-related stress, and their mental health outcome may be more likely to show up 
after the first year.
Consistent with earlier studies of mental health services use [11, 20], cancer survivors were 
more likely to report mental health services use, especially among those longer-term 
survivors (diagnosed >1 year). As others have suggested, a higher likelihood of mental 
health services use among survivors may reflect the lasting psychological effects of cancer 
[21]. Survivors may have more frequent interaction with healthcare providers and therefore 
may experience more opportunities for detection of and referral for mental health concerns. 
However, because survivors reported higher mental health services use independent of 
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insurance status and having a usual source of care, other factors beyond connection to the 
healthcare system may have also played a role. Higher mental health services use may also 
suggest better access to care. Although cancer survivors aged 18–64 reported significantly 
higher mental health needs regardless of time since diagnosis, the mental health prescription 
drugs use and expenditure were significantly lower among those diagnosed ≤1 year than 
individuals without a cancer history. This may suggest higher unmet mental health needs 
among recently diagnosed younger adult cancer survivors. Punekar et al. [21] found 
significant higher mental health prescription drugs use among younger adult cancer 
survivors compared to individuals without a cancer history. Our results suggested that 
mental health services use varied by time since diagnosis.
Several limitations of this study need to be acknowledged. First, MEPS may underestimate 
population-based estimates of mental health services use and expenditures because 
participants self-report mental health events and conditions (recall bias and/or stigma). In 
addition, MEPS respondents are community (noninstitutionalized) residents and mental 
health problems may be more severe among institutionalized population which was 
excluded from MEPS sample. Second, this study is cross-sectional; a causal relationship 
between cancer history and mental health use cannot be inferred. Additionally, inferences 
about the appropriateness of mental health services received cannot be made in this study. 
Third, detailed information about cancer stage, severity, treatment history, and other clinical 
characteristics that may be associated with subsequent mental health services use is not 
collected in MEPS, all of which may affect mental health needs and mental health services 
use [11]. Cancer survivors included in nationally representative population-based surveys 
typically consist of survivors of common adult cancers (e.g., breast and prostate), often 
participating in the survey many years after their diagnosis [37]. Fourth, our analysis only 
estimated direct medical costs, which is only part of the societal costs associated with mental 
health care among cancer survivors. There are other unmeasured costs such as productivity 
loss and transportation costs to and from healthcare which are associated with self-reported 
mental health care use.
Cancer survivors were estimated to bear higher health and economic burden associated with 
mental health problems than individuals without a cancer history, especially among younger 
adults. Timely diagnosis and treatment of mental health problems among cancer survivors is 
essential for quality cancer care delivery and cancer survivorship [37]. However, 18 % of 
survivors with psychological distress have indicated that they cannot afford mental health 
care [37]. This study further highlights the need of feasible cost-effective strategies that 
integrate routine mental health screening and treatment into care for the growing population 
of cancer survivors [38]. This study also provides data for future evaluation of return on 
investment of intervention programs addressing mental health issues among cancer 
survivors.
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